High-Cost Hemostatic Agents in Thyroid Surgery Increase Hospital Expenses Without Clinical Offsets
A micro-costing study of 1,800 thyroidectomies found that high-cost topical hemostatic agents substantially erode hospital margins under diagnosis-related group reimbursement.

